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Abstract
 
The cellular receptor for murine thymic stromal lymphopoietin (TSLP) was detected in a vari-
ety of murine, but not human myelomonocytic cell lines by radioligand binding. cDNA clones
encoding the receptor were isolated from a murine T helper cell cDNA library. TSLP receptor
(TSLPR) is a member of the hematopoietin receptor family. Transfection of TSLPR cDNA
resulted in only low affinity binding. Cotransfection of the interleukin 7 (IL-7)R
 
a
 
 chain
cDNA resulted in conversion to high affinity binding. TSLP did not activate cells from IL-
7R
 
a
 
2
 
/
 
2
 
 mice, but did activate cells from 
 
g
 
c
 
2
 
/
 
2
 
 mice. Thus, the functional TSLPR requires
the IL-7R
 
a
 
 chain, but not the 
 
g
 
c chain for signaling.
Key words: cytokine receptors • interleukin 2 receptor • interleukin 7 receptor • cytokine • 
DNA sequence
 
Introduction
 
The regulation of lymphopoiesis is orchestrated by a com-
plex, overlapping network of soluble and membrane-
bound molecules, among which IL-7 has been shown to
play a central role (1). The effects of IL-7 are mediated by
interaction with a heteromeric receptor complex consisting
of a specific IL-7 binding chain (the 
 
a
 
 subunit) and the 
 
g
 
c
chain common to the IL-2, IL-4, IL-9, and IL-15 receptor
complexes (2). This group of receptors, related by their
common use of the 
 
g
 
c chain, are otherwise distinct both in
structure and in the range of biological activities induced
by their ligands. The signaling pathways initiated by ligand
binding to these receptor complexes share significant simi-
larities, however, activating overlapping sets of kinases and
other signaling molecules (3). To date, IL-4 is the only
member of this group that has been demonstrated to medi-
ate a biological signal in the absence of the 
 
g
 
c chain, sug-
gesting that there are both 
 
g
 
c-dependent and -independent
classes of functional IL-4 receptors (4).
As described by Sims et al. in this issue (5), we have re-
cently identified and cloned a molecule termed thymic
stromal lymphopoietin (TSLP)
 
1
 
 that shares a closely over-
lapping, but distinct, profile of biological activities with IL-7.
Given this close overlap, we initiated studies to characterize
the cellular receptor for TSLP with particular attention to
the possibility that these two cytokines might share com-
mon receptor components. In this paper we describe the
binding characteristics of the TSLPR complex on lym-
phoid cells and the cloning of a TSLP-specific binding pro-
tein. We demonstrate that the IL-7R
 
a
 
 subunit is obligatory
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Abbreviations used in this paper: K
 
a
 
, affinity constant; RAG, recombina-
tion activating gene; SCF, stem cell factor; TSLP, thymic stromal lym-
phopoietin. 
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for formation of a high affinity, signaling competent
TSLPR complex, whereas the 
 
g
 
c chain is not required.
 
Materials and Methods
 
Cell Lines.
 
The TSLP-dependent NAG8/7 cell line was
maintained as described previously (6). BAF/BO3 cells were also
maintained under these conditions, except that parental BAF/
BO3 cells were supplemented with 100 ng/ml murine IL-3, and
BAF/BO3 cells expressing murine IL-7 receptor were supple-
mented with 100 ng/ml human IL-7.
 
Binding Assays.
 
Recombinant murine TSLP was expressed in
mammalian cells (CV-1/EBNA) and purified as described by
Sims et al. in this issue (5). Purified TSLP and murine IL-7 were
radiolabeled using the enzymobead radioiodination reagent (Bio-
Rad Laboratories) as described previously (7). Radiolabeled
stocks were stored at 4
 
8
 
C in RPMI 1640 containing 2% BSA, 20
mM Hepes, and 0.2% sodium azide, pH 7.2. Binding assays were
performed by a phthalate oil separation method as described pre-
viously (7). For binding assays in which TSLPR cDNA was
transfected into CV-1/EBNA cells, control experiments demon-
strated no difference in binding of TSLP to CV-1/EBNA cells
either as adherent monolayers or in suspension; hence, all binding
assays were performed with cell suspensions. CV-1/EBNA cells
were transfected with receptor cDNA using DEAE-dextran fol-
lowed by chloroquine treatment as described previously (8), and
assayed for binding 2 d later. Nonspecific binding was assessed by
including either a 1,000-fold molar excess of unlabeled TSLP and
IL-7, or polyclonal rabbit anti–murine IL-7 (at a concentration
previously determined to inhibit 
 
125
 
I–IL-7 binding) into the
binding mixture.
 
Affinity Cross-Linking.
 
Cell suspensions were incubated with
binding medium containing 0.5–1 nM 
 
125
 
I-TSLP or 
 
125
 
I–IL-7 for
3 h at 4
 
8
 
C. Nonspecific binding and cross-competition were de-
termined by using 1,000-fold molar excess of unlabeled cyto-
kines. After binding, cells were washed three times with PBS at
4
 
8
 
C, and cross-linking reagent bis-(sulfosuccinimidyl) suberate
was added to a final concentration of 0.1 mg/ml; no bis-(sulfo-
succinimidyl) suberate was added to control samples. Cells were
cross-linked for 30–45 min at 25
 
8
 
C, washed once with PBS, and
extracted in PBS/1% Triton containing 1 mM PMSF, 10 
 
m
 
M
pepstatin A, 10 
 
m
 
M leupeptin, 2 mM 
 
O
 
-phenanthroline, 1 mM
EGTA, 0.5 mM EDTA, and 0.02% sodium azide for 20–30 min
at 4
 
8
 
C. Lysed cells were centrifuged at 12,000 
 
g
 
 for 15 min at
4
 
8
 
C, and supernatants were retained. Supernatants were then an-
alyzed by autoradiography after 8–16% gradient SDS–PAGE as
described previously (9).
 
BAF/BO3 Transfection and Proliferation Assays.
 
BAF/BO3
cells were transfected with murine IL-7R
 
a
 
 cDNA by electropo-
ration as described (10). In brief, 8 
 
3 
 
10
 
6 
 
cells were washed in
RPMI 1640, 10 
 
m
 
g murine IL-7R
 
a
 
 cDNA was added (11), elec-
troporated at 280 V and 960 
 
m
 
F using a Bio-Rad Laboratories
gene pulser, and selected in 100 ng/ml human IL-7. For prolifer-
ation assays, parental and transfected BAF/BO3 cells were cul-
tured in 96-well flat-bottomed plates (1 
 
3 
 
10
 
4
 
 cells/well) with
serial threefold dilutions of murine IL-3, TSLP, or human IL-7.
The starting concentration of cytokines was 10 
 
m
 
g/ml; back-
ground was measured by adding cells to assay medium alone.
Cells were cultured for 2 d, pulsed for 5 h with 
 
3
 
H-TdR, har-
vested onto glass fiber filters, and incorporation was determined.
 
cDNA Cloning.
 
An oligo-dT–primed cDNA library from the
murine T helper cell clone 7B9 (12) was transfected into CV1/
 
EBNA cells and screened with 
 
125
 
I-TSLP essentially as described
(13). A chloroquine-mediated DEAE-dextran method (8) was
used to transfect subconfluent monolayers of CV-1/EBNA cells
grown in pronectin-treated chamber slides, with miniprep DNA
from pools of 1,000 clones from the 7B9 library. Since the 7B9
library was in an expression vector that contained the SV40 origin
of replication but lacked the Epstein-Barr virus origin, the library
plasmids (2.5 
 
m
 
g per slide) were cotransfected with pSV3neo (14)
(0.5 
 
m
 
g) as a source of T antigen to allow the plasmid to replicate
and thereby increase both the transfection efficiency and the ex-
pression level (15). After 2 d of expression, slides of transfected
cells were incubated with 1 nM 
 
125
 
I-TSLP in binding medium
containing 5% nonfat dry milk for 1 h at 25
 
8
 
C. The slides were
then washed with PBS, fixed with 2.5% glutaraldehyde in PBS,
washed, air-dried overnight, and dipped in liquid photographic
emulsion. After 3 d of exposure in the dark at 25
 
8
 
C, the slides
were developed and examined at 
 
3
 
10–20 magnification for the
presence of silver grains over cells that have bound to 
 
125
 
I-TSLP.
Positive pools were broken down and single clones were isolated
as described (13). TSLPR sequence data are available from
EMBL/GenBank/DDBJ under accession no. AF232936.
 
RNA Hybridization.
 
PolyA
 
1
 
 RNA (5 
 
m
 
g) was run on aga-
rose gels, transferred to a nylon membrane, and hybridized to a
 
32
 
P-labeled antisense riboprobe derived from the entire insert of
clone 7a as described (13). The final wash of the filters was for 60
min at 63
 
8
 
C in 0.1
 
3 
 
SSC.
 
Interspecific Mouse Backcross Mapping.
 
Interspecific backcross
progeny were generated by mating (C57BL/6J 
 
3
 
 
 
Mus spretus
 
)F
 
l
 
females and C57BL/6J males as described (16). A total of 205 N
 
2
 
mice were used to map the 
 
Tslpr 
 
locus. DNA isolation, restriction
enzyme digestion, agarose gel electrophoresis, Southern blot
transfer, and hybridization were performed essentially as described
(17). All blots were prepared with Hybond-N
 
1
 
 nylon membrane
(Amersham Pharmacia Biotech). The probe, a 1.35-kb EcoRl
 
/
 
Hindlll
 
 
 
fragment of mouse cDNA, was labeled with [
 
a
 
-
 
32
 
P]dCTP
using a random primed labeling kit (Stratagene); washing was
done to a final stringency of 0.25
 
3
 
 SSCP, 0.1% SDS, 65
 
8
 
C. A
major fragment of 3.3 kb was detected in Pvull-digested C57BL/
6J DNA and a major fragment of 3.7 kb was detected in Pvull-
digested 
 
M
 
. 
 
spretus 
 
DNA. The presence or absence of the 3.7-kb
Pvull
 
 M
 
.
 
 spretus–
 
specific
 
 
 
fragment was followed in backcross
mice.
A description of the probes and RFLPs for the loci linked to
 
Tslpr 
 
including
 
 Bmp3
 
,
 
 Gfi 1
 
,
 
 
 
and 
 
Adrbk2 
 
has been reported previ-
ously (18, 19). Recombination distances were calculated using
Map Manager, v2.6.5. Gene order was determined by minimiz-
ing the number of recombination events required to explain the
allele distribution patterns.
 
Whitlock-Witte Culture Analysis.
 
Livers were isolated from
newborn IL-7R
 
a
 
2
 
/
 
2
 
 and wild-type C57BL/6 mice. The deriva-
tion and description of mice with a targeted disruption of the IL-
7R
 
a
 
 gene have been described (20). Cultures were set up with a
modification of the method of Whitlock and Witte (21). In brief,
livers were disrupted into a single cell suspension and cultured in
RPMI 1640 plus 5% charcoal filtered FCS (Hyclone) containing
human IL-7 (10 ng/ml), or murine stem cell factor (SCF) (1 
 
m
 
g/
ml), or murine TSLP (100 ng/ml), or SCF plus TSLP in 60-mm
tissue culture dishes (Costar) and incubated at 37
 
8
 
C for 9 d. Pheno-
typic analysis was performed with FITC-conjugated RA3-6B2,
GR-1, and Mac-1 Abs. Samples were analyzed on a FACScan™
(Becton Dickinson) using either a lymphoid- or myeloid-specific
gate as determined by forward versus side light scatter profiles.
The lymphoid gate was defined by the light scatter of the cells 
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that grew out under IL-7 stimulation, and the myeloid gate was
defined by the light scatter of the cells that grew out under SCF
stimulation.
 
Thymocyte and Bone Marrow Proliferation Assays.
 
Unfraction-
ated thymocytes from mice deficient in 
 
g
 
c (22) or wild-type con-
trols were cultured in 96-well plates (2 
 
3
 
 10
 
5
 
 cells/well). Cells
were stimulated with ConA (5 
 
m
 
g/ml) alone or in combination
with IL-7 (10 ng/ml), or TSLP (10 and 0.4 ng/ml). Cells were
cultured for 72 h and were pulsed with 
 
3H-TdR for the last 6 h.
Mice deficient in both gc and recombination activating gene
(RAG)-2 (23) were obtained through intercrossing, and mutants
were identified by PCR using genomic DNA derived from tail
snips. Bone marrow was flushed from femurs and tibias and the
cells were stained with PE-conjugated anti-B220 Ab. B2201 B
cell lymphoid precursors were isolated by cell sorting using a
FACStarPLUS™ (Becton Dickinson). B cell cultures were initiated
by plating 106 sorted B2201 cells on mitomycin C–treated ST2
stromal cells (24) supplemented with TSLP (100 ng/ml). After a
period of 10 d, growth of clusters of round lymphoid cells was ob-
served which were found to consist of .95% B2201 lymphocytes.
Nonadherent cells (5 3 104) were washed and replated in 96-well
round-bottomed plates in 200 ml of RPMI 1640 supplemented
with 10% FCS, 50 mM 2-ME, nonessential amino acids, and anti-
biotics, and the following growth factor combinations: muIL-7
(50 ng/ml), TSLP (100 ng/ml), and SCF (100 ng/ml). Cells were
cultured for 2 d and pulsed with 3H-TdR for the last 12 h.
Results
Characterization of TSLP Receptors on Lymphoid Cell
Lines. Purified recombinant murine TSLP was iodinated
and shown to exhibit specific binding to both B and T lym-
phoid cell lines. Typical equilibrium binding data for 125I-
TSLP at 378C to the murine pre-B cell line 70Z/3 and the
murine T cell line 7B9 is shown in Fig. 1, A and B. Condi-
tions chosen for binding reflected preliminary experiments
that showed that binding was saturable and required ,60
min to reach equilibrium at either 37 or 48C. In both cases,
Scatchard analysis of the data indicated a single class of high
affinity binding sites for TSLP (25). For 70Z/3 cells, the
calculated affinity constant (Ka) was 7.1 6 1.2 3 109 M21
with 1,200 6 900 sites per cell (average of 12 experiments),
and for 7B9 cells, the Ka was 1.1 6 0.1 3 1010 M21 with
1,200 6 700 sites per cell (average of 2 experiments). Bind-
ing experiments with 70Z/3 cells were also performed at
48C and produced binding constants very similar to those
obtained at 378C (data not shown). These results are in con-
trast to those previously obtained with murine IL-7 where
binding to the pre-B cell line IxN/2b produced complex
biphasic curves at either 4 or 378C, indicative of both high
and low affinity IL-7 binding sites on these cells (9).
TSLPR expression was evaluated on a variety of murine
and human cell lines by radioligand binding (Table I).
TSLP binding by murine cell lines of both lymphoid and
myelomonocytic origin was detected at relatively low lev-
els. Most cell lines that bound 125I-TSLP exhibited a single
high affinity binding site with a Ka between 0.4 and 1 3
1010 M21. Interestingly, in some murine cell lines (LSTRA,
NS1.1, P815), a low affinity binding component was also
detected. This affinity was difficult to measure accurately
and was ,4  3 108 M21. These results suggest that the
TSLPR complex may consist of a low affinity binding sub-
unit that is converted to high affinity when complexed
with an additional receptor chain, as has been previously
shown for many other cytokine receptors (2). Interestingly,
cell lines that bound TSLP were also known to bind mu-
rine IL-7 (9). However, unlike murine IL-7, which is capa-
ble of binding to IL-7 receptors on human cells, none of
the human lines tested was found to bind murine TSLP.
Given that these lines represented a panel of both lymphoid
and myelomonocytic cell types quite analogous to the mu-
rine lines that bind TSLP, these data would suggest quite
strongly that murine TSLP is incapable of cross-reacting
with a putative human TSLPR.
To explore the possibility that TSLP might interact with
subunits of the IL-7 receptor, inhibition studies were per-
formed in which unlabeled TSLP, murine IL-7, and human
IL-7 were tested for their ability to inhibit binding of 125I-
TSLP to 70Z/3 cells. Both murine and human IL-7 were
capable of inhibiting 125I-TSLP binding, although not as effec-
tively as unlabeled TSLP (Fig. 2), which exhibited an inhibi-
tion constant of 9.8 3 109 M21. Also, murine IL-7 was more
effective than human IL-7 at competing for TSLP binding.
These data suggest that TSLP was able to interact with at least
one component of the IL-7 receptor complex. To gain fur-
Figure 1. Equilibrium binding of 125I-TSLP to lymphoid cell lines.
70Z/3 cells (A) and anti-CD3–stimulated 7B9 cells (B) were incubated
with various concentrations of 125I-TSLP for 30 min at 378C. Binding
was assayed as described in Materials and Methods. All data were cor-
rected for nonspecific binding. Insets show Scatchard representations of
specific binding from each panel.662 Murine TSLP Receptor
ther understanding of the nature of the TSLPR, we under-
took to clone the cDNA for a specific TSLP binding chain.
Isolation of a cDNA Clone Encoding a TSLP Binding
Chain. Cloning of a cDNA encoding the TSLPR was ac-
complished by direct expression in mammalian cells (26). A
cDNA library was generated in an expression vector using
mRNA from a murine T helper cell clone (7B9) that binds
radiolabeled TSLP. Pools of cDNA clones were transfected
into CV-1/EBNA cells and 3 d later the cells were incubated
with 125I-TSLP, with the expectation that if a pool contained
a functional TSLPR cDNA, expression of that clone would
result in TSLP binding to some of the transfected CV-1/
Table I. Distribution of TSLPRs
TSLP bound (molecules/cell)
Cell line Characteristic High Ka* Low Ka*
Murine cells
Nag8/7 TSLP-dependent pre-B cell 500–1,700 nd‡
70Z3 Pre-B cell 300–3,000 nd
IxN/2B IL-7–dependent pre-B cell 700–1,500 nd
NFS-25-C3 Pre-B lymphoblast 440 nd
NFS-5-C1 Pre-B lymphoblast 480 nd
BAF/BO3 Pre-B cell nd 250–2,500
Wehi 279 B cell nd nd
7B9 T cell clone (helper) 500–1,800 nd
CTLL IL-2–dependent T cell nd nd
EL-4 T cell thymoma nd nd
LSTRA T lymphocytic leukemia 35 7,500
FDCP-2 Myeloid nd nd
FDCP-1 Promyeloid nd 210
PU5-1.8 Macrophage 1,000 nd
P388D1 Macrophage nd nd
J774 Macrophage nd 300
Raw 264.7 Monocytic nd nd
NS1.1 Monocytic 100 1,400
P815 Mastocytoma 20 1,300
MC-6 Mast cell nd 540–2900
DA-1 Mast cell nd nd
Human cells
JM-1 Pre-B cell nd nd
EU.1 Pre-B cell nd nd
Daudi B cell lymphoma nd nd
Raji B cell lymphoma nd nd
CB23 B cell lymphoma nd nd
MP-1 B cell lymphoma nd nd
THP-1 Monocytic nd nd
U937 Monocytic nd nd
MO7E Premegakaryocytic nd nd
TF-1 Proerythrocytic nd nd
KG-1 Myelogenous leukemia nd nd
W126 Lung fibroblast nd nd
IMTLH Stromal nd nd
Binding experiments were conducted as described in Materials and Methods.  Molecules bound per cell were determined by Scatchard analysis of
complete sets of binding data and represent total sites per cell.
*High  and low affinity sites are those defined as having Ka values .4 3 109 and ,4 3 108 M21, respectively.
‡nd, not detected. Limit of detection is defined as 20 molecules bound per cell.663 Park et al.
EBNA cells. Two positive pools were found after screening
50,000 cDNA clones, which were then broken down into
successively smaller subpools until a single cDNA clone en-
coding a TSLPR was isolated from each (clones 7a and 19).
The inserts from the two clones were sequenced and found
to be identical in the extensive region of overlap.
The longer of the two TSLPR clones, clone 7a, had a
single open reading frame of 359 amino acids (Fig. 3 A).
The sequence predicts a type I transmembrane protein with
a hydrophobic signal peptide at the NH2 terminus and a
single membrane-spanning segment. The extracellular por-
tion is a member of the hematopoietin receptor family (27)
that includes the receptors for many other cytokines. The
TSLPR lacks the second of the four conserved cysteines
present in other hematopoietin family members, and in
place of the hallmark WSXWS motif contains the sequence
WTAVT. There are two potential sites for N-linked gly-
cosylation. The cytoplasmic portion is predicted to be 106
amino acids in length. It contains the “box 1” region (28)
that is common to all hematopoietin family receptors and is
thought to be a binding site for signal transducing mole-
cules. In addition, the TSLPR shows a more extended ho-
mology with the cytoplasmic regions of the erythropoietin
receptor, the IL-9 receptor, and the b chain of the IL-2 re-
ceptor (Fig. 3 B). There is a formal possibility that the nat-
ural TSLPR protein is larger than shown in Fig. 3 A, since
no in-frame stop codons are present in the 59 untranslated
region of clone 7a. If that is the case, however, the addi-
tional NH2-terminal amino acids would seem to be unnec-
essary for proper cell surface membrane expression and
TSLP binding activity of the molecule.
Expression of TSLPR mRNA in Murine Tissues and Cell
Lines. Northern blots reveal a single hybridizing RNA
species that migrates somewhat faster than 18S rRNA (Fig.
4), consistent with the mRNA size of z1,300 nucleotides
Figure 2. Inhibition of 125I-TSLP binding by unlabeled TSLP and IL-7.
70Z/3 cells (5 3 107 cells) were incubated with 125I-TSLP (2.6 3 10210
M) and varying concentrations of unlabeled TSLP (s), murine IL-7 (d),
and human IL-7 (n) for 30 min at 378C. Binding was assayed as described
in Materials and Methods. The continuous curves were calculated from
either a one-site (TSLP) or two-site (murine and human IL-7) competi-
tive inhibition equation using a Ka value for 125I-TSLP of 8.8 3 109 M21.
All data were corrected for nonspecific binding.
Figure 3. Murine TSLPR
cDNA. (A) The cDNA and pre-
dicted amino acid sequence of the
murine TSLPR clone 7a. Signal
peptide cleavage is shown by the
arrow as occurring after Ala 21, al-
though cleavage after Ala 15
would be nearly as preferred (ref-
erence 37). The transmembrane
region is underlined; asterisks
mark the cysteines conserved in
hematopoietin family members; a
double underline indicates the se-
quence WTAVT, present here
in place of the more typical
WSXWS; the box 1 sequence of
Murakami et al. is boxed (refer-
ence 28). A second functional
cDNA clone isolated in the ex-
pression screen, clone 19, extends
from nucleotide 80 through the
polyA stretch at the 39 end. The
initiating Met-Ala-Trp sequence
at the NH2 terminus of clone 7a
is replaced in clone 19 by Met-
Gly, encoded in the adapter used
to insert the cDNA into the vec-
tor. (B) Alignment of the mem-
brane-proximal segment of the
murine TSLPR with membrane-proximal segments of the murine erythro-
poietin receptor (EpoR), the murine IL-2 receptor b chain, and the murine
IL-9 receptor, with regions of amino acid conservation highlighted.664 Murine TSLP Receptor
(excluding polyA) estimated from the cDNA clones.
TSLPR mRNA was detected in EL/4 and 70Z/3 cells,
thymus, spleen, and weakly in kidney and bone marrow. It
was not detected in 3T3 cells, LMtk2 cells, brain, and liver
(Fig. 4). Expressed sequence tags derived from TSLPR
mRNA have been found in mouse cDNA libraries made
from placenta, embryo, embryonic stem cells, testes, small
intestine, brain, and macrophages.
Chromosomal Location of Tslpr. The mouse chromo-
somal location of Tslpr was determined by interspecific
backcross analysis using progeny derived from matings of
(C57BL/6J 3 M. spretus, Fl 3 C57BL/6J) mice (16). The
mapping results indicated that Tslpr is located in the central
region of mouse chromosome 5 linked to Bmp3, Gfi 1, and
Adrbk2 (data not shown). The most likely gene order is:
centromere - Bmp3 - Gfi 1 - Tslpr - Adrbk2.
Expression and Characterization of TSLPR cDNA. Evi-
dence that the isolated TSLPR clone 7a encoded a func-
tional TSLP binding protein is shown in Fig. 5, A and B.
TSLPR clone 7a expressed alone in transfected CV-1/
EBNA cells was found to bind 125I-TSLP with low affinity
only, displaying a single low affinity site with a Ka of 1.3 6
1.2 3 108 M21 (average of six experiments). This affinity is
similar to that observed for 125I-TSLP binding to a limited
subset of murine cell lines such as BAF/BO3 and MC6. To
determine if the IL-7Ra subunit might be a component of
the TSLPR complex that would increase the affinity of
TSLP binding, TSLPR cDNA was cotransfected into CV-
1/EBNA cells with either murine (Fig. 5 A) or human
(Fig. 5 B) IL-7Ra cDNA clones. Binding analysis with
125I-TSLP revealed that cells coexpressing the TSLPR and
either murine or human IL-7Ra proteins exhibited bipha-
sic binding characteristics with both high and low affinity
binding sites. The new high affinity site had a Ka of 1.8 6
1.1 3 1010 M 21 (average of five experiments), which is
similar to that observed for 125I-TSLP binding to lymphoid
and myelomonocytic cells, suggesting that the native high
affinity TSLPR complex might be comprised of just these
two components.
This hypothesis was further explored by taking advantage
of the observation that BAF/B03 cells demonstrate only
low affinity binding for 125I-TSLP (Ka , 4 3 108 M21) and
lack the IL-7Ra chain as they do not bind 125I-IL-7 (data
not shown). Additionally, this indicates that IL-7 does not
bind to TSLPR. These cells were stably transfected with
murine IL-7Ra cDNA as described above (see Materials
and Methods), and the binding affinities for 125I–muIL-7
and 125I-TSLP were measured (Fig. 5, C and D). 125I–IL-7
binding was very similar to that described previously for
other murine cell lines, exhibiting a biphasic Scatchard plot
(9). The curve shown in Fig. 5 C had 1,100 high affinity
sites with a Ka of 7 3 109 M21, and a large number of low
affinity sites (.20,000) with an affinity of ,1 3 108. In
contrast, binding of 125I-TSLP to these transfected cells
(Fig. 5 D) showed a single high affinity site with a Ka of 3.9 6
0.4 3 109 M21 with 4,500 6 3,100 sites/cell (average of
four experiments). This affinity is in the same range as that
measured for TSLP binding on the various lymphoid and
myelomonocytic cell lines shown in Table I. In addition, it
is apparent from the 125I–IL-7 binding curve that the IL-
7Ra chain is expressed in apparent excess to the number of
endogenous TSLPR chains. This ratio would explain why
all the low affinity TSLPR chains are effectively converted
to high affinity TSLP binding complexes by the presence of
the IL-7Ra chain, and suggests that in most of the cell lines
we tested for TSLP binding, the IL-7Ra is also expressed
in excess relative to the TSLPR chain.
Characterization of the TSLP Receptor by Affinity Cross-
Linking. To further characterize the TSLPR complex, we
performed affinity cross-linking studies on a cell line (70Z/3)
containing endogenous high affinity TSLPRs, on CV-1/
EBNA cells that had been transfected with only the
Figure 4. Northern blot analysis of TSLPR mRNA. PolyA1 RNA from
various cell lines and tissues was hybridized to an antisense TSLPR riboprobe
as described in Materials and Methods. The band at 28S reflects the cross-
hybridization of the TSLPR probe to residual rRNA present in the samples.
Figure 5. Binding characteristics of TSLPR with the IL-7Ra chain. (A
and B) Binding of 125I-muTSLP to CV-1/EBNA cells transfected with mu-
rine TSLPR with (d) or without (s) murine IL-7Ra (A) or human IL-
7Ra (B). (C and D) Binding of 125I–muIL-7 (C) or 125I-muTSLP (D) to
BAF/BO3 cells transfected with the murine IL-7Ra. In all cases binding was
done for 30 min at 378C and assayed as described in Materials and Methods.665 Park et al.
TSLPR clone 7a, and on BAF/BO3 cells (which express
endogenous TSLPR chain) transfected with the murine IL-
7R cDNA. On 70Z/3 cells (Fig. 6 A), cross-linking with
125I-TSLP revealed two major species with molecular
masses of z100 and 75 kD. Cross-linking of 125I-TSLP in
both of these bands is relatively evenly reduced in the pres-
ence of unlabeled murine or human IL-7 (Fig. 6 A, lanes c
and d). Incubation in the presence of unlabeled TSLP to-
tally eliminates the presence of both cross-linked species
(data not shown). After subtraction of the molecular mass
of TSLP (major species of 23 kD, with minor species of 18
kD due to differential glycosylation), the cross-linked spe-
cies would correspond to membrane proteins of z75 and
50 kD, respectively. The larger species corresponds closely
to the size of the murine IL-7R chain as previously mea-
sured by affinity cross-linking, suggesting that the smaller
species may represent the TSLPR chain (9, 11). This hy-
pothesis is substantiated by the results obtained from cross-
linking TSLP to CV-1/EBNA cells transfected with the
TSLPR clone 7a alone (Fig. 6 B). A single cross-linked
species is observed that corresponds in size to the smaller of
the two species seen on the 70Z/3 cells (Fig. 6 B, lane f),
and cross-linking of 125I-TSLP to this species is completely
inhibited by the inclusion of unlabeled TSLP in the incu-
bation mixture (Fig. 6 B, lane g). Cross-linking to BAF/
BO3 cells that contain endogenous TSLPR and transfected
recombinant murine IL-7Ra produced a pattern of cross-
linking with 125I-TSLP essentially identical to that seen on
the 70Z/3 cells (Fig. 6 C, lane i). Cross-linked complexes
of z100 and 75 kD are observed, which are competitively
inhibited by unlabeled TSLP (Fig. 6 C, lane j). To eluci-
date the nature of the higher molecular mass cross-linked
species, these cells were also cross-linked with 125I–muIL-7.
As shown in Fig. 6 C, lane k, two main cross-linked species
were observed, one of z100 kD and a larger species of
z180 kD. This pattern is very similar to what was previ-
ously observed for 125I–IL-7 cross-linking (9), where we
proposed that the higher molecular mass species may corre-
spond to cross-linking of 125I–IL-7 to a dimer of IL-7Ra
chains. The 100-kD cross-linked species corresponds closely
in size to the larger of the two species cross-linked with
125I-TSLP. Taken together, these data provide strong evi-
dence that the expressed natural and recombinant TSLPR
chains have a molecular mass of z50 kD, and that in cells
expressing both the TSLPR and IL-7Ra chains, TSLP is
capable of interacting with both.
Signal Transduction Mediated by TSLPR Complexes. Hav-
ing shown that the TSLPR is a low affinity TSLP bind-
ing chain that can be converted to a high affinity binding
complex in the presence of the IL-7Ra chain, we next
wanted to examine the signaling capabilities of these two
forms of the TSLPR. BAF/BO3 cells (which express
TSLPR and gc) that were transfected with the IL7Ra
were tested for their response to IL-3, IL-7, and TSLP. Pa-
rental BAF/BO3 cells that proliferated in response to IL-3
were incapable of responding to either human IL-7 or
TSLP even when these factors were used at very high con-
centrations (data not shown). BAF/BO3 cells transfected
with the IL-7Ra now proliferated to both IL-7 and TSLP
(Fig. 7). Although these cells proliferated to a greater extent
to IL-7, their response to TSLP was significantly greater
than background (cells with no added growth factor, P ,
0.05) at all concentrations of TSLP .1.5 ng/ml. It there-
fore appears, at least in this cell population, that the IL-
7Ra chain is required for generation of a functional
TSLPR complex.
Given that the functional IL-7Ra complex has also been
shown to contain the gc chain (29), it was necessary to de-
termine if the functional TSLPR complex requires the gc
chain and thus exists as a heterotrimer with TSLPR and IL-
7Ra, or whether the TSLPR and IL-7Ra chains are suffi-
cient for signaling. BAF/BO3 cells endogenously express
the gc chain, so the proliferative results in the IL-7Ra–
transfected BAF/BO3 line were not informative. To deter-
mine the requirement for the IL-7Ra and gc chains in for-
mation of a functional TSLPR, we therefore examined the
ability of TSLP to mediate biological activities on cells
from mice that were deficient in either the IL-7Ra chain
or the gc chain.
Analysis of TSLP Activity in Whitlock-Witte Cultures De-
rived from IL-7Ra–deficient Mice.  Whitlock-Witte cultures
were established using murine neonatal liver as the source
of hematopoietic cells from wild-type or IL-7Ra2/2 mice
(30, 31). These cells were cultured with TSLP, IL-7, SCF,
or TSLP plus SCF for 9 d. Nonadherent cells were then
harvested, counted, and analyzed by immunoflourescent
staining and flow cytometry.
As can be seen in Fig. 8 A, compared with IL-7 or SCF,
Figure 6. Characterization of the TSLPR by affinity cross-linking. (A)
70Z/3 cells were incubated with 125I-TSLP in the absence of unlabeled
competitor (a and b), or in the presence of unlabeled murine IL-7 (c) or
human IL-7 (d) and then treated with (b–d) or without (a) cross-linker.
(B) CV-1 cells transfected with TSLPR clone 7a were incubated with
125I-TSLP in the absence of unlabeled competitor (e and f) or in the pres-
ence of unlabeled TSLP (g) and then treated with (f and g) or without (e)
cross-linker. (C) BAF/BO3 cells transfected with muIL-7Ra were incu-
bated with 125I-TSLP in the absence of unlabeled competitor (h and i) or
in the presence of unlabeled TSLP (j), or with 125I–IL-7 (k) and then
treated with (i–k) or without (h) cross-linker. Cross-linking was per-
formed as described in Materials and Methods and samples were run on
SDS-PAGE under reducing conditions using 8–16% gradient gels and an-
alyzed by autoradiography.666 Murine TSLP Receptor
TSLP did not stimulate significant growth of either wild-
type or IL-7Ra–deficient cells in this culture system.
However, the nonadherent cell yield in response to TSLP
by both wild-type and IL-7Ra–deficient cells is greater
than in cultures with no added cytokine in which only an
adherent cell layer develops. The combination of TSLP
and SCF did not result in a greater degree of nonadherent
cell growth than with SCF alone in either wild-type or IL-
7Ra–deficient cells. Interestingly, phenotypic analysis of
these cultures showed that cells grown in SCF or SCF plus
TSLP had a roughly similar distribution of myeloid cells
(Fig. 8 B, myeloid gate, Mac-1 and Gr-1 staining). How-
ever, wild-type cells grown in SCF plus TSLP had a signif-
icant population of B2201 cells (Fig. 8 B, lymphoid gate)
that was not present in cultures grown in SCF alone (an in-
significant number of events was present in the lymphoid
gate to accumulate data; Fig. 8 B). IL-7Ra2/2 cells cul-
tured with SCF and TSLP resulted in only myeloid cell
growth (an insignificant number of events was present in
the lymphoid gate to accumulate data; Fig. 8 B). Thus,
these data demonstrate that TSLP alone does not stimulate
significant growth in Whitlock-Witte culture conditions,
but in the presence of SCF results in significant lymphoid
growth, compared with SCF alone which stimulates only
myeloid growth. This lymphoid population is not observed
in cultures established with IL-7R2/2 cells, further sup-
porting the hypothesis that TSLP-mediated signaling re-
quires the IL-7Ra chain.
Analysis of TSLP Activity on Cells from gc-deficient Mice.
To determine if the gc chain was involved in the TSLPR
signaling complex, the proliferative response of wild-type
and gc2/2 lymphocytes in response to TSLP was assessed.
It has been previously demonstrated that gc2/2 thymocytes
proliferate poorly in response to ConA, and that this re-
sponse cannot be augmented by the addition of exogenous
IL-2, IL-4, or IL-7 (22). As can be seen in Table II, the ad-
dition of TSLP to ConA resulted in a significant increase in
proliferation of gc2/2 thymocytes, suggesting that gc is not
required for TSLP-mediated signaling. This observation
was confirmed using B cell precursors from RAG-2–defi-
cient mice (23). These mice accumulate B cell precursors
due to an inability to rearrange Ig genes precisely at the
point where they are most responsive to the combination
of IL-7 and SCF. Thus, long term cultures of RAG-2–
deficient B cell progenitors can be maintained in vitro with
IL-7 and SCF (32). B2201 bone marrow cells from RAG-
22/2 or gc2/2RAG-22/2 double mutants were cultured on
ST2 stromal cells supplemented with TSLP. The nonad-
herent lymphoid cells that expanded expressed B220 and
IL-7Ra and were negative for surface IgM, Gr-1, and
Mac-1 (data not shown). As can be seen in Table II, these
enriched B2201 B cell precursors from gc2/2RAG-22/2
Figure 7. Proliferative response of BAF/BO3 cells transfected with the
muIL7Ra chain. BAF/BO3 cells expressing murine IL-7Ra chain (2 3
105 cells/ml) were cultured in medium alone, murine IL-3 (j), human
IL-7(d), or murine TSLP (m) for 2 d. Cells were then pulsed for 5 h
with 3H-TdR and harvested. The background cpm (cells in medium
alone) averaged 184 cpm.
Figure 8. Analysis of TSLP activity in Whitlock-Witte cultures derived from wild-type or IL-7Ra2/2 mice. (A) Livers from IL-7Ra2/2 or wild-type
newborn mice were grown under Whitlock-Witte culture conditions for 9 d in the presence of either IL-7 (10 ng/ml), SCF (1 mg/ml), TSLP (100 ng/
ml), or SCF plus TSLP. Enumeration of nonadherent cells was determined by trypan blue exclusion. (B) Immunofluorescent profiles of nonadherent cells
isolated from IL-7Ra2/2 and wild-type mice. Lymphoid and myeloid gates were established by the forward versus side light scatter profiles of cells
grown in IL-7 alone or SCF alone, respectively. Myeloid gated cells were analyzed for Mac-1 and Gr-1 expression after growth in SCF (gray histogram)
or SCF plus TSLP (white histogram). Lymphoid gated cells were analyzed for B220 expression after growth in IL-7 (hatched histogram) or SCF plus
TSLP (white histogram). Black histogram represents IgG1 isotype control staining of cells grown in IL-7.667 Park et al.
mice were able to proliferate in response to TSLP in the
presence of SCF, but not to IL-7 in the presence of SCF.
These data demonstrate that the gc is not required for the
response to TSLP by thymocytes and B cell precursors un-
der these culture conditions.
Discussion
TSLP is a cytokine that shares a closely overlapping, but
distinct, profile of biological activities with IL-7 (6). In
Sims et al. in this issue, we have reported the cloning and
further characterization of this molecule (5). In this report,
we utilize purified recombinant-derived murine TSLP to
characterize the cell surface receptor complex to which this
cytokine binds, and report cloning of a cDNA encoding a
specific murine TSLP binding chain. Equilibrium binding
studies with radiolabeled TSLP demonstrated that a variety
of murine lymphoid, myeloid, and monocytic cell lines
were capable of binding TSLP, in most cases exhibiting a
single high affinity binding site. However, there were a few
cell lines that exhibited both a high and low affinity site,
and three lines that exhibited low affinity binding only.
This pattern of binding is reminiscent of several other cy-
tokine receptors that contain two or more subunits, in par-
ticular those that contain a specific low affinity binding
chain, and an additional converting subunit that generates a
high affinity, signal tranduction competent complex.
Given the apparent biological relationship of TSLP to
IL-7, it was also interesting to note that all the cell lines that
were found to bind TSLP had been previously demon-
strated to bind IL-7. This suggested the possibility that the
receptors for TSLP and IL-7 might share one or more
common subunits. Subsequent binding inhibition and
cross-linking studies substantiated this hypothesis and led to
our efforts to clone a receptor subunit that might specifi-
cally bind TSLP. A cDNA clone encoding a TSLP binding
chain (TSLPR) was isolated by direct expression from a
murine 7B9 T helper cell clone cDNA library. The se-
quence predicts a type I transmembrane protein that is
clearly a member of the hematopoietin receptor family, but
with interesting variations. The TSLPR lacks the second of
the four conserved cysteines present in other hematopoi-
etin family members, and in place of the hallmark WSXWS
motif it contains the sequence WTAVT. The cytoplasmic
portion contains the “box 1” region that is common to all
hematopoietin family receptors and is thought to be a
binding site for signal transducing molecules (28). In addi-
tion, the TSLPR sequence shows extended homology with
the cytoplasmic regions of the erythropoeitin receptor, the
IL-9R, and the b chain of the IL-2R.
Following up on the possibility that TSLP and IL-7
might share common receptor subunits, the binding of
TSLP to TSLPR, both in the presence and absence of IL-
7Ra, was examined by expressing these subunits in CV-1/
EBNA cells. The results showed that the TSLPR subunit
alone bound TSLP with low affinity whereas the combina-
tion of TSLPR and IL-7Ra generated a high affinity site.
The affinities of both these sites matched those previously
measured in murine cell lines. Interestingly, both the mu-
rine and human IL-7Ra subunits were equally effective in
combining with the murine TSLPR subunit to generate a
high affinity murine TSLP binding complex. This was
somewhat surprising since extensive binding studies failed to
identify any human cell lines capable of binding murine
TSLP, indicating that this molecule exhibits strict species
specificity. In contrast, both murine and human IL-7 are ca-
pable of binding to receptors on cells of the opposite species.
Further characterization of TSLPR-mediated binding
and signal transduction was done by using the BAF/B03
cell line, which expresses endogenous TSLPR and gc, but
no IL-7Ra. This line binds TSLP with low affinity only,
does not bind IL-7, and is incapable of proliferating in re-
sponse to either cytokine. When a stable transfectant of this
line was generated that expressed the IL-7Ra subunit as
well, the cells were now found to bind both IL-7 and
TSLP with high affinity and to proliferate in response to
these cytokines. This result indicated that, at a minimum,
the TSLPR and IL-7Ra subunits were required to gener-
ate a functional TSLPRcomplex. This conclusion was fur-
ther substantiated by the observation that in Whitlock-
Witte cultures established from IL-7Ra2/2 mice, TSLP
was incapable of stimulating cell growth. TSLP did show
activity in this culture system, however. When combined
with SCF, TSLP stimulated growth of wild-type B2201
cells that were absent in cultures grown in SCF alone.
Signal transduction in the IL-7 receptor complex re-
quires the gc chain, first described for the IL-2 receptor
complex (29, 33). The possibility that the gc might be in-
volved in TSLP signal transduction was tested functionally
by studying the in vitro proliferative response of thy-
Table II. Proliferative Response of Thymocytes and B2201 Cells 
from gc2/2 Mice to TSLP
gc2/2 gc1/1
cpm 3 1023
Thymocytes
ConA 4.7 7.2
ConA 1 IL-7 4.6 25.6
ConA 1 TSLP 10 ng/ml 11.5 15.3
ConA 1 TSLP 0.4 ng/ml 11.2 10.9
PMA/ionomycin 49.5 52.4
PMA/IL-4 0.2 44.1
B2201 cells (RAG-22/2)
SCF 0.2 0.5
IL-7 0.4 11.2
IL-7/SCF 0.5 20.3
TSLP 1.7 1.6
TSLP/SCF 11.6 5.6
Enriched B2201 cells are from gc2/2RAG-22/2 and gc1/1RAG-22/2
mice (see Materials and Methods). The values are the arithmetic mean
of triplicate wells and are from a single representative experiment.668 Murine TSLP Receptor
mocytes and pre-B cells from gc2/2 mice to IL-7 and
TSLP. In each case, there was an insignificant response of
gc2/2 cells to IL-7, as expected; however, gc2/2 cells were
still competent to respond to TSLP. In total, these data in-
dicate that high affinity binding and biological activity of
TSLP require the IL-7Ra chain, but do not require the gc
chain of the IL-2R complex.
The relationship of TSLP and IL-7 to their cellular recep-
tors is analogous to the IL-13–IL-4 cytokine–receptor sys-
tem in which IL-13–mediated signaling through the IL-
13R utilizes the IL-4Ra chain but not the gc chain (34,
35). Interestingly, both IL-7 and TSLP have overlapping bi-
ological activities as well as unique properties. Both IL-7
and TSLP promote growth of B cell and T cell precursors;
however, the unique biological responses generated through
binding of TSLP to the TSLPR–IL-7Ra complex have yet
to be well understood. A recent report describes the ability
of TSLP and IL-7 to induce tyrosine phosphorylation of the
signal transducer and activator of transcription (Stat)5 tran-
scription factor. TSLP did not induce activation of Janus ki-
nase 1 and Janus kinase 3, whereas IL-7–mediated signaling
did so in the same cell line (36). This evidence indicates that
TSLP will have biological effects that are not common to
IL-7, and these remain to be elucidated in detail.
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